Filing Details

Accession Number:
0001225208-23-000630
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-13 18:41:05
Reporting Period:
2023-01-13
Accepted Time:
2023-01-13 18:41:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204551 A Michael Mussallem One Edwards Way
Irvine CA 92614
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-13 29,375 $35.20 186,728 No 4 M Direct
Common Stock Disposition 2023-01-13 9,500 $0.00 177,228 No 4 G Direct
Common Stock Disposition 2023-01-13 19,875 $78.09 157,353 No 4 S Direct
Common Stock Acquisiton 2023-01-13 9,500 $0.00 3,482,517 No 4 G Indirect By Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 G Direct
No 4 S Direct
No 4 G Indirect By Living Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2023-01-13 29,375 $0.00 29,375 $35.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
117,500 2016-06-12 2023-05-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 371,705 Indirect 401(k)
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.
  2. This transaction was executed in multiple trades at prices ranging from $77.43 to $78.40 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.